NEW YORK, Nov. 5 – Bruker Daltonics has agreed to develop a bench-top mass spectrometer to be integrated into a new Sequenom MassArray genotyping system for medium throughput analysis, the companies said Monday.

Under the terms of the deal Bruker Daltonics will develop a new GenoFlex system based on MALDI-TOF mass spectrometry. Sequenom currently uses a similar Bruker-based platform for its high-throughput MassArray system. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.